Skip to main content

Peer Review reports

From: A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

Original Submission
6 May 2009 Submitted Original manuscript
9 Jun 2009 Reviewed Reviewer Report - Neil Thomson
3 Aug 2009 Reviewed Reviewer Report - Lanny Rosenwasser
21 Sep 2009 Author responded Author comments - Nestor Molfino
Resubmission - Version 2
21 Sep 2009 Submitted Manuscript version 2
23 Dec 2009 Author responded Author comments - Nestor Molfino
Resubmission - Version 3
23 Dec 2009 Submitted Manuscript version 3
Publishing
8 Jan 2010 Editorially accepted
8 Jan 2010 Article published 10.1186/1471-2466-10-3

You can find further information about peer review here.

Back to article page